首页> 美国卫生研究院文献>Reumatologia >Observational study of inflammatory arthritis treatment by etanercept originator switched to an etanercept biosimilar

【2h】

Observational study of inflammatory arthritis treatment by etanercept originator switched to an etanercept biosimilar

机译：依那西普始发者转用依那西普生物仿制药治疗炎性关节炎的观察研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

The aim of the study was to assess the safety and efficacy of switching an etanercept originator to an etanercept biosimilar in rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, and ankylosing spondylitis patients.

机译：该研究的目的是评估在风湿性关节炎，幼年特发性关节炎，银屑病关节炎和强直性脊柱炎患者中将依那西普始用药转换为依那西普生物仿制药的安全性和有效性。

著录项

期刊名称 Reumatologia
作者
Anna Felis-Giemza; Kornelia Chmurzyńska; Jolanta Nałęcz-Janik; Katarzyna Romanowska-Próchnicka; Katarzyna Świerkocka; Mariusz Wudarski; Marzena Olesińska;
展开▼
作者单位

展开▼
年(卷),期 2019(57),5
年度 2019
页码 -1
总页数 7
原文格式 PDF
正文语种
中图分类外科学;
关键词
inflammatory arthritis; biologics switching etanercept; biosimilar;

机译：炎性关节炎;生物制剂转换依那西普;生物仿制药;

相似文献

外文文献
中文文献
专利

1. Observational study of inflammatory arthritis treatment by etanercept originator switched to an etanercept biosimilar [J] . Anna Felis-Giemza, Kornelia Chmurzyńska, Jolanta Na??cz-Janik, Reumatologia . 2019,第5期

机译：依那西普始发者转用依那西普生物仿制药治疗炎性关节炎的观察研究
2. One-year follow-up of a nationwide cohort of patients with inflammatory arthritis, who switched from originator to biosimilar etanercept, focusing on patients who switched back to originator: an observational DANBIO study [J] . Glintborg B., Sorensen I. J., Omerovic E., Scandinavian journal of rheumatology . 2018,第Suppla129期

机译：一年的全国性炎性关节炎患者的一年后续随访，他们从发起者转向生物仿制物的entanectpect，专注于转回发起者的患者：观察丹比奥研究
3. To switch or not to switch: results of a nationwide guideline of mandatory switching from originator to biosimilar etanercept. One-year treatment outcomes in 2061 patients with inflammatory arthritis from the DANBIO registry [J] . Glintborg Bente, Loft Anne Gitte, Omerovic Emina, Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research . 2019,第2期

机译：切换或不切换：从发起者到生物仿制物的强制性切换的全国性指南的结果。 2061例丹比奥登记处炎症关节炎患者的一年治疗结果
4. ETANERCEPT IN THE TREATMENT OF AA AMYLOIDOSfS IN JUVENILE RHEUMATOID ARTHRITIS-PRELIMINARY EXPERIENCE [C] . H. Michels, R. Hafner, R.P. Link International Symposium on Amyloidosis . 2005

机译：依赖替辛醚治疗少年类风湿性关节炎中AA淀粉样液 - 初步体验
5. A prospective observational study of immediately loaded platform switched 3i implants [D] . Chi, Jackie 2009

机译：立即加载平台切换3i植入物的前瞻性观察研究
6. Original article: Does a mandatory non-medical switch from originator to biosimilar etanercept lead to increase in healthcare use and costs? A Danish register-based study of patients with inflammatory arthritis [O] . Bente Glintborg, Rikke Ibsen, Rebecca Elisabeth Qwist Bilbo, 2019

机译：原始文章：强制性的非医疗方式从发起者转为仿制药依那西普会导致医疗保健使用和成本增加吗？基于丹麦注册的炎性关节炎患者研究
7. Observational study of inflammatory arthritis treatment by etanercept originator switched to an etanercept biosimilar [O] . Anna Felis-Giemza, Kornelia Chmurzyńska, Jolanta Nałęcz-Janik, 2019

机译：Etanercept oundator切换到Etanercept BioSimilar的炎症性关节炎治疗的观察性研究

Observational study of inflammatory arthritis treatment by etanercept originator switched to an etanercept biosimilar

摘要

著录项

相似文献

相关主题

期刊订阅